These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Angiotensin converting enzyme inhibitors reduce alcohol consumption: some possible mechanisms and important conditions for its therapeutic use. Lingham T; Perlanski E; Grupp LA Alcohol Clin Exp Res; 1990 Feb; 14(1):92-9. PubMed ID: 2178480 [TBL] [Abstract][Full Text] [Related]
3. The renin-angiotensin system: a multidimensional source of control over alcohol consumption. Grupp LA Alcohol Alcohol Suppl; 1991; 1():421-6. PubMed ID: 1726987 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin converting enzyme inhibitors: animal experiments suggest a new pharmacological treatment for alcohol abuse in humans. Spinosa G; Perlanski E; Leenen FH; Stewart RB; Grupp LA Alcohol Clin Exp Res; 1988 Feb; 12(1):65-70. PubMed ID: 2831750 [TBL] [Abstract][Full Text] [Related]
5. Interactions of the systemic and brain renin-angiotensin systems in the control of drinking and the central mediation of pressor responses. Robinson MM; McLennan GP; Thunhorst RL; Johnson AK Brain Res; 1999 Sep; 842(1):55-61. PubMed ID: 10526095 [TBL] [Abstract][Full Text] [Related]
6. Manipulations of the renin-angiotensin system and intake of a sweetened alcoholic beverage among rats. Hubbell CL; Chrisbacher GA; Bilsky EJ; Reid LD Alcohol; 1992; 9(1):53-61. PubMed ID: 1310248 [TBL] [Abstract][Full Text] [Related]
7. Time-dependent effect of the angiotensin converting enzyme inhibitor, abutapril, on voluntary alcohol intake in the rat. Grupp LA; Chow SY Alcohol Alcohol; 1992 May; 27(3):267-71. PubMed ID: 1449562 [TBL] [Abstract][Full Text] [Related]
8. The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition. Keuneke C; Yacullo R; Metzger R; Hellmann T; Peters J; Ganten D Eur Heart J; 1990 May; 11 Suppl D():11-6. PubMed ID: 2163328 [TBL] [Abstract][Full Text] [Related]
9. [Role of angiotensin II in the mechanisms of ethanol consumption regulation in rats]. Kotov AV; Kelesheva LF; Kuznetsov SL; Pal'tsev MA Biull Eksp Biol Med; 1982 Jun; 93(6):68-71. PubMed ID: 6889448 [TBL] [Abstract][Full Text] [Related]
10. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats. Bolterman RJ; Manriquez MC; Ortiz Ruiz MC; Juncos LA; Romero JC Hypertension; 2005 Oct; 46(4):943-7. PubMed ID: 16087785 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibition with quinapril (CI-906) and captopril in spontaneously hypertensive rats with suppressed renin-angiotensin system. Säynävälammi P; Pörsti I Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):325-31. PubMed ID: 3309510 [TBL] [Abstract][Full Text] [Related]
13. Effects of angiotensin II and an angiotensin converting enzyme inhibitor on alcohol intake in P and NP rats. Grupp LA Pharmacol Biochem Behav; 1992 Jan; 41(1):105-8. PubMed ID: 1539057 [TBL] [Abstract][Full Text] [Related]
14. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats. Gonzalez Vera W; Fournié-Zaluski MC; Pham I; Laboulandine I; Roques BP; Michel JB J Pharmacol Exp Ther; 1995 Jan; 272(1):343-51. PubMed ID: 7815350 [TBL] [Abstract][Full Text] [Related]
15. Effects of chronic converting enzyme inhibition on the vascular renin-angiotensin system. Saito H; Nakamaru M; Rakugi H; Mikami H; Ogihara T; Inagami T Clin Exp Pharmacol Physiol; 1990 Nov; 17(11):745-53. PubMed ID: 2150362 [TBL] [Abstract][Full Text] [Related]
16. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril. Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542 [TBL] [Abstract][Full Text] [Related]
17. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats. Paull JR; Widdop RE J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847 [TBL] [Abstract][Full Text] [Related]
18. Plasticity and impact of the central renin-angiotensin system during development of ethanol dependence. Sommer WH; Rimondini R; Marquitz M; Lidström J; Siems WE; Bader M; Heilig M J Mol Med (Berl); 2007 Oct; 85(10):1089-97. PubMed ID: 17823780 [TBL] [Abstract][Full Text] [Related]
19. Regulation of insulin-like growth factor-1 by the renin-angiotensin system during regression of cardiac eccentric hypertrophy through angiotensin-converting enzyme inhibitor and AT1 antagonist. Haddad GE; Blackwell K; Bikhazi A Can J Physiol Pharmacol; 2003 Feb; 81(2):142-9. PubMed ID: 12710528 [TBL] [Abstract][Full Text] [Related]
20. Development of inhibitors of the aspartyl protease renin for the treatment of hypertension. Scott BB; McGeehan GM; Harrison RK Curr Protein Pept Sci; 2006 Jun; 7(3):241-54. PubMed ID: 16787263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]